HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,612,726 | +65.9% | 173,108 | +56.7% | 0.04% | +75.0% |
| Q2 2023 | $3,985,014 | -21.7% | 110,480 | -17.1% | 0.02% | -28.6% |
| Q1 2023 | $5,087,214 | -15.3% | 133,208 | +26.2% | 0.03% | -20.0% |
| Q4 2022 | $6,005,169 | +263.7% | 105,539 | +181.3% | 0.04% | +250.0% |
| Q2 2022 | $1,651,000 | +624.1% | 37,513 | +603.5% | 0.01% | +900.0% |
| Q4 2020 | $228,000 | +53.0% | 5,332 | -54.1% | 0.00% | 0.0% |
| Q2 2017 | $149,000 | -47.2% | 11,625 | -42.2% | 0.00% | -50.0% |
| Q1 2014 | $282,000 | – | 20,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |